Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 71

1.

Standardization of Flow Cytometric Immunophenotyping for Hematological Malignancies: The FranceFlow Group Experience.

Solly F, Angelot-Delettre F, Ticchioni M, Geneviève F, Rambaud H, Baseggio L, Plesa A, Debliquis A, Garnache-Ottou F, Roggy A, Campos L, Aanei C, Rosenthal-Allieri A, Georget MT, Lachot S, Jacob MC, Robillard N, Wuilleme S, Andre-Kerneis E, Cornet E, Salaun V, Bennami H, Lhoumeau AC, Arnoulet C, Jacqmin H, Neyman N, Latger-Cannard V, Massin F, Lainey E, Le Garff-Tavernier M, Costopoulos M, Roussel M, Mayeur-Rousse C, Eischen A, Raggeneau V, Derrieux C, Maurer M, Asnafi V, Trinquand A, Brouzes C, Lhermitte L.

Cytometry A. 2019 Sep;95(9):1008-1018. doi: 10.1002/cyto.a.23844. Epub 2019 Jul 31.

PMID:
31364809
2.

High-Dose Rituximab and Early Remission in PLA2R1-Related Membranous Nephropathy.

Seitz-Polski B, Dahan K, Debiec H, Rousseau A, Andreani M, Zaghrini C, Ticchioni M, Rosenthal A, Benzaken S, Bernard G, Lambeau G, Ronco P, Esnault VLM.

Clin J Am Soc Nephrol. 2019 Aug 7;14(8):1173-1182. doi: 10.2215/CJN.11791018. Epub 2019 Jul 24.

PMID:
31340979
3.

Obinutuzumab and ibrutinib induction therapy followed by a minimal residual disease-driven strategy in patients with chronic lymphocytic leukaemia (ICLL07 FILO): a single-arm, multicentre, phase 2 trial.

Michallet AS, Dilhuydy MS, Subtil F, Rouille V, Mahe B, Laribi K, Villemagne B, Salles G, Tournilhac O, Delmer A, Portois C, Pegourie B, Leblond V, Tomowiak C, de Guibert S, Orsini F, Banos A, Carassou P, Cartron G, Fornecker LM, Ysebaert L, Dartigeas C, Truchan Graczyk M, Vilque JP, Aurran T, Cymbalista F, Lepretre S, Lévy V, Nguyen-Khac F, Le Garff-Tavernier M, Aanei C, Ticchioni M, Letestu R, Feugier P.

Lancet Haematol. 2019 Sep;6(9):e470-e479. doi: 10.1016/S2352-3026(19)30113-9. Epub 2019 Jul 16.

PMID:
31324600
4.

Determination of acceptable limits of precision parameters for lymphocyte count by flow cytometry.

Durrieu F, Brouzes C, Lambert C, Ticchioni M.

Ann Biol Clin (Paris). 2018 Dec 1;76(6):687-693. doi: 10.1684/abc.2018.1397.

PMID:
30543194
5.

Acceptable "Real-Life" Variability for Lymphocyte Counts by Flow Cytometry.

Ticchioni M, Brouzes C, Durrieu F, Lambert C; Association Française de Cytométrie accreditation working group (AFC-AG).

Cytometry B Clin Cytom. 2018 Dec 7. doi: 10.1002/cyto.b.21751. [Epub ahead of print]

PMID:
30525287
6.

Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation.

Aanei CM, Jacob MC, Veyrat-Masson R, Picot T, Rosenthal-Allieri MA, Lhoumeau AC, Ticchioni M, Dumezy F, Campos Catafal L.

J Vis Exp. 2018 Nov 3;(141). doi: 10.3791/57867.

PMID:
30451229
7.

Is active hepatitis C associated with the size of HIV reservoir in successfully treated patients?

Vassallo M, Durant J, Ticchioni M, Demonte A, Fabre R, Pradier C, Cottalorda J.

J Clin Virol. 2018 Nov;108:103-104. doi: 10.1016/j.jcv.2018.09.018. Epub 2018 Sep 27. No abstract available.

PMID:
30290324
8.

Only Follow-Up of Memory B Cells Helps Monitor Rituximab Administration to Patients with Neuromyelitis Optica Spectrum Disorders.

Lebrun C, Cohen M, Rosenthal-Allieri MA, Bresch S, Benzaken S, Marignier R, Seitz-Polski B, Ticchioni M.

Neurol Ther. 2018 Dec;7(2):373-383. doi: 10.1007/s40120-018-0101-4. Epub 2018 Jun 7.

9.

Erratum to 'HMGB1/anti-HMGB1 antibodies define a molecular signature of early stages of HIV-Associated Neurocognitive Disorders (HAND)'.

Gougeon ML, Poirier-Beaudouin B, Durant J, Lebrun-Frenay C, Saïdi H, Seffer V, Ticchioni M, Chanalet S, Carsenti H, Harvey-Langton A, Laffon M, Cottalorda J, Pradier C, Dellamonica P, Vassallo M.

Heliyon. 2017 Mar 16;3(3):e00259. doi: 10.1016/j.heliyon.2017.e00259. eCollection 2017 Mar.

10.

HMGB1/anti-HMGB1 antibodies define a molecular signature of early stages of HIV-Associated Neurocognitive Isorders (HAND).

Gougeon ML, Poirier-Beaudouin B, Durant J, Lebrun-Frenay C, Saïdi H, Seffer V, Ticchioni M, Chanalet S, Carsenti H, Harvey-Langton A, Laffon M, Cottalorda J, Pradier C, Dellamonica P, Vassallo M.

Heliyon. 2017 Feb 13;3(2):e00245. doi: 10.1016/j.heliyon.2017.e00245. eCollection 2017 Feb. Erratum in: Heliyon. 2017 Mar 16;3(3):e00259.

11.

Monitoring CD27+ memory B-cells in neuromyelitis optica spectrum disorders patients treated with rituximab: Results from a bicentric study.

Cohen M, Romero G, Bas J, Ticchioni M, Rosenthal M, Lacroix R, Brunet C, Rico A, Pelletier J, Audoin B, Lebrun C.

J Neurol Sci. 2017 Feb 15;373:335-338. doi: 10.1016/j.jns.2017.01.025. Epub 2017 Jan 10.

PMID:
28131216
12.

A decreasing CD4/CD8 ratio over time and lower CSF-penetrating antiretroviral regimens are associated with a higher risk of neurocognitive deterioration, independently of viral replication.

Vassallo M, Fabre R, Durant J, Lebrun-Frenay C, Joly H, Ticchioni M, DeSalvador F, Harvey-Langton A, Dunais B, Laffon M, Cottalorda J, Dellamonica P, Pradier C.

J Neurovirol. 2017 Apr;23(2):216-225. doi: 10.1007/s13365-016-0490-z. Epub 2016 Nov 4.

PMID:
27815816
13.

Therapeutic target of memory B cells depletion helps to tailor administration frequency of rituximab in myasthenia gravis.

Lebrun C, Bourg V, Bresch S, Cohen M, Rosenthal-Allieri MA, Desnuelle C, Ticchioni M.

J Neuroimmunol. 2016 Sep 15;298:79-81. doi: 10.1016/j.jneuroim.2016.07.009. Epub 2016 Jul 11.

PMID:
27609279
14.

Neuromyelitis optica: Contribution of therapeutic responses markers monitoring in patients given rituximab.

Romero G, Ticchioni M, Cohen M, Rosenthal-Allieri MA, Mondot L, Lebrun Frenay C.

Rev Neurol (Paris). 2016 Mar;172(3):220-4. doi: 10.1016/j.neurol.2015.12.004. Epub 2016 Feb 23. Review.

PMID:
26915311
15.

Virologically suppressed patients with asymptomatic and symptomatic HIV-associated neurocognitive disorders do not display the same pattern of immune activation.

Vassallo M, Durant J, Lebrun-Frenay C, Fabre R, Ticchioni M, Andersen S, DeSalvador F, Harvey-Langton A, Dunais B, Cohen-Codar I, Montagne N, Cua E, Fredouille-Heripret L, Laffon M, Cottalorda J, Dellamonica P, Pradier C.

HIV Med. 2015 Aug;16(7):431-40. doi: 10.1111/hiv.12246. Epub 2015 May 18.

16.

Early infectious acute respiratory distress syndrome is characterized by activation and proliferation of alveolar T-cells.

Risso K, Kumar G, Ticchioni M, Sanfiorenzo C, Dellamonica J, Guillouet-de Salvador F, Bernardin G, Marquette CH, Roger PM.

Eur J Clin Microbiol Infect Dis. 2015 Jun;34(6):1111-8. doi: 10.1007/s10096-015-2333-x. Epub 2015 Feb 5.

PMID:
25652606
17.

In vivo and in vitro sensitivity of blastic plasmacytoid dendritic cell neoplasm to SL-401, an interleukin-3 receptor targeted biologic agent.

Angelot-Delettre F, Roggy A, Frankel AE, Lamarthee B, Seilles E, Biichle S, Royer B, Deconinck E, Rowinsky EK, Brooks C, Bardet V, Benet B, Bennani H, Benseddik Z, Debliquis A, Lusina D, Roussel M, Solly F, Ticchioni M, Saas P, Garnache-Ottou F.

Haematologica. 2015 Feb;100(2):223-30. doi: 10.3324/haematol.2014.111740. Epub 2014 Nov 7.

18.

Effects of low-dose recombinant interleukin 2 to promote T-regulatory cells in alopecia areata.

Castela E, Le Duff F, Butori C, Ticchioni M, Hofman P, Bahadoran P, Lacour JP, Passeron T.

JAMA Dermatol. 2014 Jul;150(7):748-51. doi: 10.1001/jamadermatol.2014.504.

PMID:
24872229
19.

Can high central nervous system penetrating antiretroviral regimens protect against the onset of HIV-associated neurocognitive disorders?

Vassallo M, Durant J, Biscay V, Lebrun-Frenay C, Dunais B, Laffon M, Harvey-Langton A, Cottalorda J, Ticchioni M, Carsenti H, Pradier C, Dellamonica P.

AIDS. 2014 Feb 20;28(4):493-501. doi: 10.1097/QAD.0000000000000096.

PMID:
24472743
20.

T cells from chronic bone infection show reduced proliferation and a high proportion of CD28⁻ CD4 T cells.

Kumar G, Roger PM, Ticchioni M, Trojani C, Bernard de Dompsur R, Bronsard N, Carles M, Bernard E.

Clin Exp Immunol. 2014 Apr;176(1):49-57. doi: 10.1111/cei.12245.

21.

Relevance of lipopolysaccharide levels in HIV-associated neurocognitive impairment: the Neuradapt study.

Vassallo M, Dunais B, Durant J, Carsenti-Dellamonica H, Harvey-Langton A, Cottalorda J, Ticchioni M, Laffon M, Lebrun-Frenay C, Dellamonica P, Pradier C.

J Neurovirol. 2013 Aug;19(4):376-82. doi: 10.1007/s13365-013-0181-y. Epub 2013 Jul 12.

PMID:
23846287
22.

The role of lipopolysaccharide as a marker of immune activation in HIV-1 infected patients: a systematic literature review.

Vassallo M, Mercié P, Cottalorda J, Ticchioni M, Dellamonica P.

Virol J. 2012 Aug 27;9:174. doi: 10.1186/1743-422X-9-174. Review.

23.

Safety and efficacy of antigen-specific regulatory T-cell therapy for patients with refractory Crohn's disease.

Desreumaux P, Foussat A, Allez M, Beaugerie L, Hébuterne X, Bouhnik Y, Nachury M, Brun V, Bastian H, Belmonte N, Ticchioni M, Duchange A, Morel-Mandrino P, Neveu V, Clerget-Chossat N, Forte M, Colombel JF.

Gastroenterology. 2012 Nov;143(5):1207-1217.e2. doi: 10.1053/j.gastro.2012.07.116. Epub 2012 Aug 8.

PMID:
22885333
24.

The early phase of human sepsis is characterized by a combination of apoptosis and proliferation of T cells.

Roger PM, Hyvernat H, Ticchioni M, Kumar G, Dellamonica J, Bernardin G.

J Crit Care. 2012 Aug;27(4):384-93. doi: 10.1016/j.jcrc.2012.04.010.

PMID:
22824083
25.

Blastic plasmacytoid dendritic cell neoplasm: a report of four cases and review of the literature.

Borchiellini D, Ghibaudo N, Mounier N, Del Giudice P, Quinsat D, Ticchioni M, Perrin C, Cardot Leccia N, Lacour JP.

J Eur Acad Dermatol Venereol. 2013 Sep;27(9):1176-81. doi: 10.1111/j.1468-3083.2012.04503.x. Epub 2012 Mar 27. Review.

PMID:
22455538
26.

New sequential treatment with chemotherapy and reduced-intensity conditioning for allogeneic stem-cell transplantation in very high-risk acute myeloid leukemia.

Cluzeau T, De Matteis M, Mounier N, Mannone L, Gratecos N, Ticchioni M, Thyss A, Raynaud S, Cassuto JP, Sirvent A.

Am J Hematol. 2011 Jul;86(7):619-21. doi: 10.1002/ajh.22029. Epub 2011 Apr 20. No abstract available.

27.

Cell-penetrating TAT-FOXO3 fusion proteins induce apoptotic cell death in leukemic cells.

Essafi M, Baudot AD, Mouska X, Cassuto JP, Ticchioni M, Deckert M.

Mol Cancer Ther. 2011 Jan;10(1):37-46. doi: 10.1158/1535-7163.MCT-10-0482.

28.

Intracavitary cidofovir for human herpes virus-8-associated primary effusion lymphoma in an HIV-negative patient.

Stingaciu S, Ticchioni M, Sudaka I, Haudebourg J, Mounier N.

Clin Adv Hematol Oncol. 2010 May;8(5):367-74. No abstract available.

PMID:
20551896
29.

The suppression of immune activation during enfuvirtide-based salvage therapy is associated with reduced CCR5 expression and decreased concentrations of circulating interleukin-12 and IP-10 during 48 weeks of longitudinal follow-up.

Carsenti-Dellamonica H, Saïdi H, Ticchioni M, Guillouet de Salvador F, Dufayard Cottalorda J, Garraffo R, Dellamonica P, Durant J, Gougeon ML.

HIV Med. 2011 Feb;12(2):65-77. doi: 10.1111/j.1468-1293.2010.00848.x.

30.

Immune changes in post-menopausal osteoporosis: the Immunos study.

Breuil V, Ticchioni M, Testa J, Roux CH, Ferrari P, Breittmayer JP, Albert-Sabonnadière C, Durant J, De Perreti F, Bernard A, Euller-Ziegler L, Carle GF.

Osteoporos Int. 2010 May;21(5):805-14. doi: 10.1007/s00198-009-1018-7. Epub 2009 Oct 30.

PMID:
19876583
31.

The tyrosine kinase Syk regulates the survival of chronic lymphocytic leukemia B cells through PKCdelta and proteasome-dependent regulation of Mcl-1 expression.

Baudot AD, Jeandel PY, Mouska X, Maurer U, Tartare-Deckert S, Raynaud SD, Cassuto JP, Ticchioni M, Deckert M.

Oncogene. 2009 Sep 17;28(37):3261-73. doi: 10.1038/onc.2009.179. Epub 2009 Jul 6.

PMID:
19581935
32.

Spleen tyrosine kinase functions as a tumor suppressor in melanoma cells by inducing senescence-like growth arrest.

Bailet O, Fenouille N, Abbe P, Robert G, Rocchi S, Gonthier N, Denoyelle C, Ticchioni M, Ortonne JP, Ballotti R, Deckert M, Tartare-Deckert S.

Cancer Res. 2009 Apr 1;69(7):2748-56. doi: 10.1158/0008-5472.CAN-08-2690. Epub 2009 Mar 17.

33.

Molecular allelokaryotyping of early-stage, untreated chronic lymphocytic leukemia.

Lehmann S, Ogawa S, Raynaud SD, Sanada M, Nannya Y, Ticchioni M, Bastard C, Kawamata N, Koeffler HP.

Cancer. 2008 Mar 15;112(6):1296-305. doi: 10.1002/cncr.23270.

34.

Homeostatic chemokines increase survival of B-chronic lymphocytic leukemia cells through inactivation of transcription factor FOXO3a.

Ticchioni M, Essafi M, Jeandel PY, Davi F, Cassuto JP, Deckert M, Bernard A.

Oncogene. 2007 Nov 1;26(50):7081-91. Epub 2007 May 14.

PMID:
17496928
35.

Interactions between CD47 and thrombospondin reduce inflammation.

Lamy L, Foussat A, Brown EJ, Bornstein P, Ticchioni M, Bernard A.

J Immunol. 2007 May 1;178(9):5930-9.

36.

National standardization of ZAP-70 determination by flow cytometry: the French experience.

Le Garff-Tavernier M, Ticchioni M, Brissard M, Salmon C, Raynaud S, Davi F, Bernard A, Merle-Béral H, Ajchenbaum-Cymbalista F, Letestu R.

Cytometry B Clin Cytom. 2007 Mar;72(2):103-8.

37.

Evaluation of ZAP-70 expression by flow cytometry in chronic lymphocytic leukemia: A multicentric international harmonization process.

Letestu R, Rawstron A, Ghia P, Villamor N, Boeckx N, Boettcher S, Buhl AM, Duerig J, Ibbotson R, Kroeber A, Langerak A, Le Garff-Tavernier M, Mockridge I, Morilla A, Padmore R, Rassenti L, Ritgen M, Shehata M, Smolewski P, Staib P, Ticchioni M, Walker C, Ajchenbaum-Cymbalista F.

Cytometry B Clin Cytom. 2006 Jul 15;70(4):309-14. Erratum in: Cytometry B Clin Cytom. 2008 Jul;74(4):259. Leuven, Nancy Boeckx [corrected to Boeckx, Nancy].

38.

Intrahepatic CD4 T-Cell apoptosis is related to METAVIR score in patients with chronic hepatitis C virus.

Roger PM, Chaillou S, Breittmayer JP, Dahman M, St Paul MC, Chevallier P, Benzaken S, Ticchioni M, Bernard A, Dellamonica P, Tran A.

Scand J Immunol. 2005 Aug;62(2):168-75.

39.

Influence of beta 1 integrin intracytoplasmic domains in the regulation of VLA-4-mediated adhesion of human T cells to VCAM-1 under flow conditions.

Rosenthal-Allieri MA, Ticchioni M, Breittmayer JP, Shimizu Y, Bernard A.

J Immunol. 2005 Jul 15;175(2):1214-23.

40.

Apoptosis of naive CD4+ T-cells from HIV-infected patients with poor immune response to HAART is enhanced in vitro by steroid.

Roger PM, Perbost I, Ticchioni M, Fuzibet JG, Breittmayer JP, Durant J, Pesce A, Bernard A, Dellamonica P; Groupe d'Etudes Niçois Polyvalent en Infectiologie.

J Infect. 2004 Oct;49(3):216-21.

PMID:
15337338
41.

Apoptosis and proliferation kinetics of T cells in patients having experienced antiretroviral treatment interruptions.

Roger PM, Durant J, Ticchioni M, Halfon P, Breittmayer JP, Brignone C, Chaillou S, Dunais B, Dellamonica P, Bernard A; Groupe D'Etudes Nicois Polyvalent En Infectiologie.

J Antimicrob Chemother. 2003 Aug;52(2):269-75. Epub 2003 Jul 1.

PMID:
12837745
42.

CD47 and the 19 kDa interacting protein-3 (BNIP3) in T cell apoptosis.

Lamy L, Ticchioni M, Rouquette-Jazdanian AK, Samson M, Deckert M, Greenberg AH, Bernard A.

J Biol Chem. 2003 Jun 27;278(26):23915-21. Epub 2003 Apr 10.

43.

Involvement of a CD47-dependent pathway in platelet adhesion on inflamed vascular endothelium under flow.

Lagadec P, Dejoux O, Ticchioni M, Cottrez F, Johansen M, Brown EJ, Bernard A.

Blood. 2003 Jun 15;101(12):4836-43. Epub 2003 Feb 27.

44.

Signaling through ZAP-70 is required for CXCL12-mediated T-cell transendothelial migration.

Ticchioni M, Charvet C, Noraz N, Lamy L, Steinberg M, Bernard A, Deckert M.

Blood. 2002 May 1;99(9):3111-8.

45.

Integrin-associated protein (CD47/IAP) contributes to T cell arrest on inflammatory vascular endothelium under flow.

Ticchioni M, Raimondi V, Lamy L, Wijdenes J, Lindberg FP, Brown EJ, Bernard A.

FASEB J. 2001 Feb;15(2):341-50.

PMID:
11156950
46.

Persistent viral load in patients on HAART is associated with a higher level of activation-induced apoptosis of CD4(+) T cells.

Roger PM, Breittmayer JP, Cottalorda J, Ticchioni M, Mondain V, Dellamonica P, Bernard A.

J Antimicrob Chemother. 2001 Jan;47(1):109-12.

PMID:
11152441
47.

Membrane raft association of CD47 is necessary for actin polymerization and protein kinase C theta translocation in its synergistic activation of T cells.

Rebres RA, Green JM, Reinhold MI, Ticchioni M, Brown EJ.

J Biol Chem. 2001 Mar 9;276(10):7672-80. Epub 2000 Dec 12.

48.

CD99 (E2) up-regulates alpha4beta1-dependent T cell adhesion to inflamed vascular endothelium under flow conditions.

Bernard G, Raimondi V, Alberti I, Pourtein M, Widjenes J, Ticchioni M, Bernard A.

Eur J Immunol. 2000 Oct;30(10):3061-5.

49.

[Mycobacterium avium-positive pulmonary sample and CD4+ lymphopenia not related to human HIV].

Roger PM, Vandenbos F, Mondain-Miton V, Ticchioni M, Dellamonica P.

Rev Med Interne. 2000 Jan;21(1):116-7. French. No abstract available.

PMID:
10685467
50.

Cell spreading distinguishes the mechanism of augmentation of T cell activation by integrin-associated protein/CD47 and CD28.

Reinhold MI, Green JM, Lindberg FP, Ticchioni M, Brown EJ.

Int Immunol. 1999 May;11(5):707-18.

PMID:
10330276

Supplemental Content

Loading ...
Support Center